EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H36O7 |
| Net Charge | 0 |
| Average Mass | 424.534 |
| Monoisotopic Mass | 424.24610 |
| SMILES | [H][C@@]12C(=C[C@@H](O)C[C@@H]1OC(=O)[C@@H](C)CC)C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(=O)O |
| InChI | InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1 |
| InChIKey | TUZYXOIXSAXUGO-PZAWKZKUSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme. |
| Applications: | anticholesteremic drug A substance used to lower plasma cholesterol levels. anticholesteremic drug A substance used to lower plasma cholesterol levels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pravastatin (CHEBI:63618) has functional parent (S)-2-methylbutyric acid (CHEBI:38655) |
| pravastatin (CHEBI:63618) has functional parent (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid (CHEBI:63655) |
| pravastatin (CHEBI:63618) has role anticholesteremic drug (CHEBI:35821) |
| pravastatin (CHEBI:63618) has role environmental contaminant (CHEBI:78298) |
| pravastatin (CHEBI:63618) has role metabolite (CHEBI:25212) |
| pravastatin (CHEBI:63618) has role xenobiotic (CHEBI:35703) |
| pravastatin (CHEBI:63618) is a 3-hydroxy carboxylic acid (CHEBI:61355) |
| pravastatin (CHEBI:63618) is a carbobicyclic compound (CHEBI:36785) |
| pravastatin (CHEBI:63618) is a carboxylic ester (CHEBI:33308) |
| pravastatin (CHEBI:63618) is a hydroxy monocarboxylic acid (CHEBI:35868) |
| pravastatin (CHEBI:63618) is a secondary alcohol (CHEBI:35681) |
| pravastatin (CHEBI:63618) is a statin (semi-synthetic) (CHEBI:87633) |
| pravastatin (CHEBI:63618) is conjugate acid of pravastatin(1−) (CHEBI:63660) |
| Incoming Relation(s) |
| pravastatin(1−) (CHEBI:63660) is conjugate base of pravastatin (CHEBI:63618) |
| IUPAC Name |
|---|
| (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid |
| INNs | Source |
|---|---|
| pravastatin | ChemIDplus |
| pravastatina | ChemIDplus |
| pravastatine | ChemIDplus |
| pravastatinum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid | ChEBI |
| pravastatin acid | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 2239 | DrugCentral |
| C00000565 | KNApSAcK |
| C01844 | KEGG COMPOUND |
| D08410 | KEGG DRUG |
| DB00175 | DrugBank |
| HMDB0005022 | HMDB |
| LSM-3347 | LINCS |
| Pravastatin | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:4825538 | Reaxys |
| CAS:81093-37-0 | KEGG COMPOUND |
| CAS:81093-37-0 | ChemIDplus |
| Citations |
|---|